Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age.
Mar MasiáMarta Fernández-GonzálezManuel SánchezMar CarvajalJosé Alberto GarcíaNieves Gonzalo-JiménezVictoria Ortiz de la TablaVanesa AgullóInmaculada CandelaJorge GuijarroJosé Antonio GutiérrezCarlos de GregorioFelix GutiérrezPublished in: Open forum infectious diseases (2021)
The nasopharyngeal Panbio COVID-19 Ag test performed at point-of-care has a good sensitivity in symptomatic patients with Ct <30 and older age. The test was useful to identify asymptomatic patients with lower Ct values.